Boehringer Ingelheim Press Releases

Quick access for journalists to the latest press releases that cover corporate, research & development, prescription, industrial, animal health and consumer pharmaceutical news.

General Information Patients & Carers Health Care Professional in the US Health Care Professional outside the US Journalists Jobseekers

PRESS RELEASE

Press Release Overview

Here you can find an overview list of our recent Press Releases in 2016/2017.

Read more
- BIC_Flagge.jpg
PRESS RELEASE 02 Aug 2017 at 10:00

Boehringer Ingelheim achieves good growth in the first half of 2017

Read moreon
Boehringer Ingelheim achieves good growth in the first half of 2017
PRESS RELEASE 24 Jul 2017 at 09:00

People with idiopathic pulmonary fibrosis (IPF) reveal high burden of disease in new survey

Read moreon
People with idiopathic pulmonary fibrosis (IPF) reveal high burden of disease in new survey
PRESS RELEASE 29 Jun 2017 at 08:30

'More than Systemic Sclerosis: The Inside Story' – patients reveal the unseen impact of lung fibrosis

Read moreon
'More than Systemic Sclerosis: The Inside Story' – patients reveal the unseen impact of lung fibrosis
- BI X
PRESS RELEASE 08 Jun 2017 at 12:45

Boehringer Ingelheim builds Digital Lab “BI X” with focus on innovative digital solutions in healthcare

Read moreon
Boehringer Ingelheim builds Digital Lab “BI X” with focus on innovative digital solutions in healthcare
PRESS RELEASE 16 May 2017 at 13:00

Boehringer Ingelheim strengthens early science portfolio through comprehensive multifaceted partnership with Peking University

Read moreon
Boehringer Ingelheim strengthens early science portfolio through comprehensive multifaceted partnership with Peking University
PRESS RELEASE 16 May 2017 at 05:00

Boehringer Ingelheim Inaugurates World-Class Biopharmaceutical Manufacturing Facility in China

Read moreon
Boehringer Ingelheim Inaugurates World-Class Biopharmaceutical Manufacturing Facility in China
PRESS RELEASE 10 May 2017 at 11:00

Boehringer Ingelheim Phase II trial now enrolling patients with the kidney disease Lupus Nephritis

Read moreon
Boehringer Ingelheim Phase II trial now enrolling patients with the kidney disease Lupus Nephritis
PRESS RELEASE 05 Apr 2017 at 13:00

Boehringer Ingelheim: A New World Leader in Animal Health

Read moreon
Boehringer Ingelheim: A New World Leader in Animal Health
PRESS RELEASE 05 Apr 2017 at 10:30

Successful financial year 2016 for Boehringer Ingelheim

Read moreon
Successful financial year 2016 for Boehringer Ingelheim
- Free-range hens (chicken) on an organic farm-639108910 .jpg
PRESS RELEASE 30 Mar 2017 at 14:00

Novozymes and Boehringer Ingelheim announce Strategic Collaboration in Probiotics for Poultry Hatcheries

Read moreon
Novozymes and Boehringer Ingelheim announce Strategic Collaboration in Probiotics for Poultry Hatcheries
- R&D
PRESS RELEASE 02 Mar 2017 at 14:00

Boehringer Ingelheim expands collaboration with Vanderbilt University to tackle some of the most difficult-to-treat cancers

Read moreon
Boehringer Ingelheim expands collaboration with Vanderbilt University to tackle some of the most difficult-to-treat cancers
- IMP
PRESS RELEASE 02 Mar 2017 at 09:00

Boehringer Ingelheim sponsors the new building of the Research Institute of Molecular Pathology in Vienna with EUR 52 million

Read moreon
Boehringer Ingelheim sponsors the new building of the Research Institute of Molecular Pathology in Vienna with EUR 52 million
PRESS RELEASE 28 Feb 2017 at 08:00

New global survey results show: 2 out of 3 patients said they were involved in the decision-making process about the most appropriate treatment in IPF

Read moreon
New global survey results show: 2 out of 3 patients said they were involved in the decision-making process about the most appropriate treatment in IPF
- Lung
PRESS RELEASE 15 Feb 2017 at 14:00

Boehringer Ingelheim and Weill Cornell Medicine announce new collaboration to discover next generation COPD treatments

Read moreon
Boehringer Ingelheim and Weill Cornell Medicine announce new collaboration to discover next generation COPD treatments
- Press_release_card_lung_cancer.jpg
PRESS RELEASE 09 Feb 2017 at 14:27

Afatinib to be evaluated in combination with PD-1 inhibitor pembrolizumab in new trial for patients with squamous cell carcinoma of the lung

Read moreon
Afatinib to be evaluated in combination with PD-1 inhibitor pembrolizumab in new trial for patients with squamous cell carcinoma of the lung
PRESS RELEASE 02 Jan 2017 at 07:00

Sanofi and Boehringer Ingelheim confirm Closing of business swap on January 1st 2017

Read moreon
Sanofi and Boehringer Ingelheim confirm Closing of business swap on January 1st 2017
PRESS RELEASE 28 Nov 2016 at 14:00

Boehringer Ingelheim and China Southeast University collaborate to develop new treatment approaches for hearing loss

Read moreon
Boehringer Ingelheim and China Southeast University collaborate to develop new treatment approaches for hearing loss
PRESS RELEASE 14 Nov 2016 at 11:00

New analysis from the IntroDia^{^®} survey reveals how people with type 2 diabetes are informed of their diagnosis

Read moreon
New analysis from the IntroDia^{^®} survey reveals how people with type 2 diabetes are informed of their diagnosis
- Press_release_card_lung_cancer.jpg
PRESS RELEASE 08 Nov 2016 at 09:30

New European study highlights differing priorities in physician’s therapy goals when treating advanced lung cancer patients

Read moreon
New European study highlights differing priorities in physician’s therapy goals when treating advanced lung cancer patients